12 May 2020 | Berlin, Germany

Agenda

Tuesday
12 May 2020
13:30 – 15:30
Biotech / Pharma Session

Replace - Reduce - Refine (3R) and Organ-on-a-Chip: New approaches for animal protection in science

 

Welcome

Dr. Christine Mißler, Berlin Partner for Business and Technology 

 

Status quo and introduction into the topic from Pharma’s point of view

Dr. Thorsten Ruppert, vfa - German Association of Research-Based Pharmaceutical Companies

 

Charité3R- Implementation of the 3R principle to support translational research

Dr. Annemarie Lang, Charité – Universitätsmedizin Berlin

 

Bayer’s 3R activities and the role of local partners

Thomas Steger-Hartmann, Bayer 

 

Short Talk with SME’s: Different aspects of 3R

 

Closing Remarks

Dr. Christine Mißler, Berlin Partner for Business and Technology 

Conference
13:30 – 17:30
Cooperation Track

Companies, universities and research institutions are invited to apply for a short presentation.

The Cooperation Track offers an opportunity to companies and scientific institutions to introduce themselves in a five minute pitch, to make themselves known to a broad audience and to network. The focus is on the biotech, medtech, pharmaceutical and digital health sectors.

If you are interested in presenting your company, institution or project please send a short description to Volker Erb  (volker.erb@berlin-partner.de).


Cooperation track
13:30 – 15:30
Digital Health

Innovation – Validation – Transformation:
Challenges and best practices in evidence-development


In recent months, there has been plenty of buzz generated around the Digitale Versorgung Gesetz (DVG), a new law promising a fast track to reimbursement of digital solutions within the German Statutory Healthcare System (SHI). The law itself aims to create a catalogue of digital health solutions to be covered by the statutory system and prescribed by physicians

In this session, we want to examine "Care Delivery Improvements" (Positive Versorgungseffekte) in the context of the DVG and discuss specific challenges and best practices in evidence development for digital health solutions.

Session Keynote:
“The new fast track program for health care apps in Germany: bye-bye evidence?”
Dr. med. Matthias Perleth
Federal Joint Committee - Medical Consultancy Department

Panel Discussion

Dr. med. Matthias Perleth
Federal Joint Committee - Medical Consultancy Department

Dr. Alexander Krannich
Charité - Universitätsmedizin Berlin - Charité Coordinating Center for Clinical Studies

Dr. Hanne Horvath
GET.ON Institut für Online-Gesundheitstrainings GmbH

Julian Ramirez (Moderation)
Berlin Partner for Business and Technology


Conference
13:30 – 14:30
Matchmaking Session #1
Matchmaking
14:30 – 15:30
Matchmaking Session #2
Matchmaking
15:30 – 16:30
Matchmaking Session #3
Matchmaking
16:00 – 18:00
Biotech / Pharma Session

Rare diseases: Specifics and status quo – challenges and outlook


Welcome and introduction

Dr. Sabine Sydow, vfa bio

 

Are pharma and biotech companies active in research and development of orphan drugs?

Martina Ochel, Sanofi Genzyme

  

Diagnosing and treating patients with rare diseases: A multidisciplinary approach?

Prof. Heiko Krude, Berlin Center for Rare Diseases at Charité

  

Can Ada’s AI help in diagnosing rare diseases?

Dr. Martin Hirsch, Ada Health

  

What are the experiences and wishes of patients with rare diseases?

Mirjam Mann, ACHSE

  

Diagnosing and treating rare diseases: what difference can a good location make despite the ongoing digitalization? The example of Berlin.

Heidrun Irschik-Hadjieff, Takeda

Conference
16:00 – 18:00
MedTech Session

Innovation – Validation – Transformation:
Bringing technology into hospitals

 

In the coming years, new technology and software solutions - such as robotics, artificial intelligence, virtual and augmented reality, and next generation health management tools - will transform healthcare. 
Furthermore, existing solutions and medical device manufacturing processes are changing due to new technological developments and new regulatory frameworks.  
The BIONNALE Medtech Session will showcase how hospitals and manufacturers are prepared for the transformation and how they are adopting innovations in the hospital setting. 


Moderation: Sandra Wirsching, Editor in Chief Medtech Zwo


Augmented Reality: From Star Wars into the Cath Lab
Dr. Olaf Göing, Sana Kliniken


Improving Surgical Uncertainty Using Machine Learning
Ph.D. Enes Hoşgör, surgical.ai


Cooperation, apps and next generation electronic medical record in the cloud
Olaf Dörge, Cerner


Innovative & compliant: lessons learned from a business model adaption of an SME
Dr. Dominik Karch, Berlin Heart


Panel Discussion: Bringing technology into hospitals under consideration of regulatory and reimbursement pathways


Dr. Daniel Diekmann, ID Information und Dokumentation im Gesundheitswesen

Dr. Olaf Göing, Sana Kliniken

N.N., IGES Institut

Moderation: Sandra Wirsching, Editor in Chief Medtech Zwo




Conference
16:30 – 17:30
Matchmaking Session #4
Matchmaking
17:30 – 18:30
Matchmaking Session #5
Matchmaking
18:30 – 22:00
Evening reception with Industry Keynote and Speed Lecture Award

Welcome & Introduction

Dr. Kai Bindseil

Clustermanager HealthCapital Berlin-Brandenburg

 

Speed Lectures

Scientists present their work in a battle for “The Best Science Pitch”

 

Moderator: Ulrike Pfohl  

CELLphenomics GmbH

 

Keynote

Prof. Dr. Roland Eils 
Founding Director of the BIH Digital Health Center

 

Björn von Siemens

Managing Director caresyntax GmbH



Speed Lecture Award Ceremony

The winner of the audience voting will be announced

 

 

Get Together

Conference
The event agenda's time zone is CEST.